549
Views
6
CrossRef citations to date
0
Altmetric
Pediatrics

Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: a cost-effectiveness analysis

, MD, MScORCID Icon, , MD, MSc & , MD, PhDORCID Icon
Pages 949-958 | Received 02 Mar 2019, Accepted 01 Jun 2019, Published online: 17 Jun 2019

References

  • Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics 2009;123:S131–S45. Epub 2009/04/16. doi:10.1542/peds.2008-2233C.
  • Dennis RJ, Caraballo L, Garcia E, Rojas MX, Rondon MA, Perez A, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a cross-sectional study. BMC Pulmonary Med 2012;12:17. Epub 2012/05/04. PubMed PMID: 22551171; PubMed Central PMCID: PMCPMC3488963. doi:10.1186/1471-2466-12-17.
  • Hasegawa K, Bittner JC, Nonas SA, Stoll SJ, Watase T, Gabriel S, Herrera V, et al. Children and Adults With Frequent Hospitalizations for Asthma Exacerbation, 2012-2013: A Multicenter Observational Study. J Allergy Clin Immunol Practice 2015;3:751–758.e1. Epub 2015/06/02. doi:10.1016/j.jaip.2015.05.003.
  • Asher I, Pearce N. Global burden of asthma among children. Int J Tuber Lung Dis: J Int Union Tuber Lung Dis 2014;18:1269–1278. Epub 2014/10/10. doi:10.5588/ijtld.14.0170.
  • Guıa de Practica Clinica (GPC) para el diagnostico, atencion integral y seguimiento de ninos y ninas con diagnostico de asma. http://gpc.minsalud.gov.co/guias/Pages/Guı´a-de-Available from: http://asma-en-ninos.aspx (last accessed 18 January 2019).
  • Global Initiative for Asthma. Global strategy for Asthma Management and Prevention, 2018. Available from: http://www.ginasthma.org (last accessed 21 January 2019).
  • Alangari AA. Corticosteroids in the treatment of acute asthma. Ann Thoracic Med 2014;9:187–192. Epub 2014/10/03. PubMed PMID: 25276236; PubMed Central PMCID: PMCPMC4166064. doi:10.4103/1817-1737.140120.
  • Chen A-h, Zeng G-q, Chen R-c, Zhan J-y, Sun L-h, Huang S-k, Yang C-z, et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology (Carlton, Vic) 2013;18:47–52. doi:10.1111/resp.12168.
  • Edmonds ML, Milan SJ, Camargo CA, Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2012;12:Cd002308. Epub 2012/12/14. doi: 10.1002/14651858.CD002308.pub2. PubMed PMID: 2323558.doi:9
  • Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006;130:1301–1311. doi:10.1378/chest.130.5.1301.
  • de Benedictis FM, Bush A. Corticosteroids in respiratory diseases in children. Am J Resp Crit Care Med 2012;185:12–23. Epub 2011/09/17. doi:10.1164/rccm.201107-1174CI.
  • Kumar SD, Emery MJ, Atkins ND, Danta I, Wanner A. Airway mucosal blood flow in bronchial asthma. Am J Resp Crit Care Med 1998;158:153–156. Epub 1998/07/09. doi:10.1164/ajrccm.158.1.9712141.
  • Nuhoglu Y, Atas E, Nuhoglu C, Iscan M, Ozcay S. Acute effect of nebulized budesonide in asthmatic children. J Invest Allergol Clin Immunol 2005;15:197–200. Epub 2005/11/03.
  • Sung L, Osmond MH, Klassen TP. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad Emer Med: J Soc Acad Emer Med 1998;5:209–213. Epub 1998/04/02.
  • Razi CH, Akelma AZ, Harmanci K, Kocak M, Kuras Can Y. The addition of inhaled budesonide to standard therapy shortens the length of stay in hospital for asthmatic preschool children: A randomized, double-blind, placebo-controlled trial. Int Arch Aller Immunol 2015;166:297–303. Epub 2015/06/06. doi:10.1159/000430443.
  • Alangari AA, Malhis N, Mubasher M, Al-Ghamedi N, Al-Tannir M, Riaz M, Umetsu DT, et al. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: a double-blind, randomized, controlled trial. Chest 2014;145:772–778. Epub 2014/01/05. doi:10.1378/chest.13-2298.
  • Doan Q, Shefrin A, Johnson D. Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the pediatric emergency department. Pediatrics 2011;127:e1105–11. Epub 2011/04/06. doi:10.1542/peds.2010-2963.
  • Kassisse E, Prada L, Salazar I, Garcia H, Kassisse J. Open randomized study of children with acute exacerbation of asthma and treated with inhaled steroids. Rev Cubana Pediatr 2017; 89:165–176.
  • Sano F, Cortez GK, Sole D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J Aller Clin Immunol 2000;105:699–703. Epub 2000/04/11. doi:10.1067/mai.2000.104784.
  • Upham BD, Mollen CJ, Scarfone RJ, Seiden J, Chew A, Zorc JJ. Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. Acad Emer Med: J Soc Acad Emer Med 2011;18:665–673. Epub 2011/07/19. doi:10.1111/j.1553-2712.2011.01114.x.
  • Razi CH, Corut N, Andiran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatr Pulmonol 2017;52:720–728. Epub 2017/01/14. doi:10.1002/ppul.23667.
  • Sistema de Información de precios de medicamentos— SISMED. Listado de precios promedio y unidades en la cadena de comercialización de medicamentos. Ministerio de la Protección Social. República de Colombia. Available from: http://web.sispro.gov.co/WebPublico/Consultas/ConsultarCNPMCa denaComercializacionCircu2yPA_028_2_2.aspx (last accessed 15 January 2019).
  • Souliotis K, Kousoulakou H, Hillas G, Bakakos P, Toumbis M, Loukides S, et al. Direct and indirect costs of asthma management in Greece: an expert panel approach. Front Public Health 2017;5:67. Epub 2017/04/21. PubMed PMID: 28424767; PubMed Central PMCID: PMCPMC5380663. doi:10.3389/fpubh.2017.00067.
  • Banco de la Republica, Colombia. Series estadisticas. Tasas de cambio. Santa Fe de Bogota: Banco de la República; 2011. Available from: http://www.banrep.gov.co/series-estadisticas/see_ts_cam.htm (last accessed 19 January 2019).
  • Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
  • O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150–163. Epub 1994/02/01.
  • Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Dec Making: Int J Soc Med Dec Making 2002;22:290–308. Epub 2002/08/02. doi:10.1177/0272989x0202200408.
  • Himmelstein DU, Jun M, Busse R, Chevreul K, Geissler A, Jeurissen P, Thomson S, et al. A comparison of hospital administrative costs in eight nations: US costs exceed all others by far. Health Affairs (Project Hope) 2014;33:1586–1594. Epub 2014/09/10. doi:10.1377/hlthaff.2013.1327.
  • Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA 2018;319:1024–1039. Epub 2018/03/15. doi:10.1001/jama.2018.1150.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.